<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01142674</url>
  </required_header>
  <id_info>
    <org_study_id>T-Cell Project</org_study_id>
    <nct_id>NCT01142674</nct_id>
  </id_info>
  <brief_title>T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma</brief_title>
  <official_title>Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Associazione Angela Serra per la ricerca sul cancro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Italiana Linfomi ONLUS</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>International Peripheral T-Cell Lymphoma Project (Study group)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Associazione Angela Serra per la ricerca sul cancro</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The designed study follows up the retrospective previous one by the International T-cell
      Non-Hodgkin's Lymphoma Study Group (International Peripheral T-Cell Lymphoma Project).

      It is designed as a prospective collection of information potentially useful to predict the
      prognosis of newly diagnosed patients with the more frequent subtypes of Peripheral T-cell
      lymphoma (Peripheral T-cell lymphoma unspecified and Angioimmunoblastic T-cell lymphoma) and
      to better define clinical characteristics and outcome of the more uncommon subtypes
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Peripheral T-cell lymphomas (PTCLs) comprise a heterogeneous group of neoplasms that are
      derived from post-thymic lymphoid cells at different stages of differentiation with different
      morphological patterns, phenotypes, and clinical presentations. PTCLs are highly diverse,
      reflecting the diverse cells from which they can originate. Peripheral T-Cell Lymphomas
      account for 5-10% of all lymphoproliferative disorders in the Western hemisphere, with an
      overall incidence of 0.5-2 per 100,000 per year, and have a striking epidemiological
      distribution, with higher incidence in Asia.

      The clinical features of PTCLs are extremely heterogeneous. PTCLs express even more clinical
      diversity than B-cell NHLs, and there is a close, though not absolute, relationship between
      some unusual clinical features and certain histological subtypes. Despite efforts to
      transferring to patients with T-cell lymphomas the most recent advances in the treatment of
      other subtypes of B-cell lymphomas, the prognosis of patients with PTCL is still poor an,
      unfortunately, the optimal therapy for PTCL is still unknown. The complete response rate is
      rather low, ranging from 40% to 50% with a median Relapse Free Survival (RFS) of 2-3 years.
      As a consequence of the aggressiveness of the disease and of the low efficacy of available
      salvage treatments, Overall Survival (OS) is also short and the long-term survival rate is
      lower than 10% in many series.

      To better define the clinical outcome of PTCL-NOS, the Intergruppo Italiano Linfomi (IIL, now
      Fondazione Italiana Linfomi, FIL) performed a large study on 385 patients diagnosed and
      treated in the 1990s and defined a prognostic model specifically devised for patients with
      this uncommon disease (Gallamini, A. et al Blood, 2004. 103(7): p. 2474-9). In addition to
      defining a prognostic model specifically devised for PTCL-NOS, the FIL study confirms the
      relevance of research on series of clearly defined cases in order to the development of
      rationally designed and potentially more-efficacious treatment modalities. More recently, the
      role of biological features of the disease is emerging as an important issue not only for
      understanding its pathogenesis but also for prognosis and for addressing specific biologic
      targets altered in the neoplasia. Significant progress in the prognosis of PTCL can be
      expected from the novel, sophisticated, and powerful technologies of genomics and proteomics,
      which will allow more reliable subtyping of PTCL into distinct clinical groups characterized
      by different patterns of survival, as already demonstrated for some B-NHLs.

      One common limitation of existing studies on prognosis of PTCL is their retrospective nature.
      Currently available data are based on analysis performed on series collected over a long
      period of time. This aspect is very important as it may introduce relevant biases in the
      collected series. First classification systems have changed dramatically over time and cases
      may have been defined in differently based on diagnosis year. Second some clinical or
      laboratory data which now are considered as prognostic relevant may have not been determined
      in older series of patients. Third in a retrospective analysis there is no guarantee that
      collected series are based on real consecutive cases. These are the reasons why we thought it
      would be useful to start a new study based on the prospective registration in a short period
      of time of patients with diagnosis of Peripheral T-cell lymphoma for whom it would be
      possible collect an exhaustive set of clinical data and biological information.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Survival (OS)</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Event Free Survival (EFS)</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Remission rate with initial therapy</measure>
    <time_frame>End of front-line therapy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression Free Survival (PFS)</measure>
    <time_frame>5-years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Lymphoma, T-Cell, Peripheral</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Formalin-fixed tissue for central diagnostic pathology review
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Previously-untreated patients with de novo diagnosis of peripheral T-cell or NK/T-cell
        lymphoma
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Previously-untreated patients with de novo diagnosis of peripheral T-cell or NK/T-cell
             lymphoma:

               -  Peripheral T-cell lymphoma unspecified;

               -  Peripheral T-cell lymphoma, lymphoepithelioid variant;

               -  Peripheral T-cell lymphoma, T-zone variant ;

               -  Peripheral T-cell lymphoma, parafollicular variant ;

               -  Angioimmunoblastic T-cell lymphoma;

               -  Nasal NK/T-cell lymphoma;

               -  NK/T-cell lymphoma, nasal time;

               -  Anaplastic large-cell lymphoma, T/null cell, ALK+, primary systemic type

               -  Anaplastic large-cell lymphoma, T/null cell, ALK-, primary systemic type

               -  Anaplastic large cell lymphoma, small cell variant, ALK+

               -  Anaplastic large cell lymphoma, lymphohistiocytic variant, ALK+

               -  Enteropathy- type T-cell lymphoma;

               -  Hepatosplenic T-cell lymphoma;

               -  Peripheral gamma-delta T-cell lymphoma;

               -  Subcutaneous panniculitis-like T-cell lymphoma;

               -  Unclassifiable peripheral T-cell Lymphoma

               -  Unclassifiable NK-cell lymphoma

          2. Age over 18

          3. Tissue biopsies adequate for diagnosis and classification and available for
             centralized review

          4. Clinical data including baseline information on disease localization and laboratory
             parameters at staging, features of treatment adopted and assurance of follow-up
             updating for at least 5 years are requested

          5. Written informed consent

        Exclusion Criteria:

          1. Age &lt; 18

          2. Diagnosis of T-cell or NK-cell leukemia or proliferation and other than mature types
             including:

               -  Adult T-cell leukemia/lymphoma;

               -  Blastic NK-cell leukemia/lymphoma;

               -  Aggressive NK-cell leukemia

               -  T-cell large granular lymphocytic leukemia

               -  T-cell large granular lymphocytic proliferation

               -  NK-cell large granular lymphocytic proliferation

               -  T-cell prolymphocytic leukemia

               -  Precursor T-cell lymphoblastic leukemia/lymphoma

               -  Mycosis fungoides;

               -  Sézary syndrome;

               -  Primary cutaneous ALCL
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Massimo Federico, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dip. Medicina Diagnostica - Università di Modena e Reggio Emilia, , Modena, IT</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julie M. Vose, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Nebraska Medical Center, Omaha, NE, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Emanuele Zucca, MD</last_name>
    <role>Study Chair</role>
    <affiliation>IOSI/Oncology Institute of Southern Switzerland, Ospedale S. Giovanni - Bellinzona, CH</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joseph M Connors, MD</last_name>
    <role>Study Chair</role>
    <affiliation>British Columbia Cancer Agency, Vancouver, CA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven M. Horwitz, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Francine M. Foss, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Yale Cancer Center, New Haven, CT, USA</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pier Luigi Zinzani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Istituto di Ematologia e Oncologia Medica &quot;L. e A. Seragnoli&quot;, Policlinico Sant'Orsola, Bologna, IT</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Silvia Montoto, MD</last_name>
    <role>Study Chair</role>
    <affiliation>St. Bartholomew Hospital, London, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aaron Polliack, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Sourasky Medical Center, Tel Aviv, IL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefano A. Pileri, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Università di Bologna, IT &amp; Istituto Europeo di Oncologia, Milano, IT</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Young H. Ko, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Samsung Medical Center, Seoul, KR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Monica Bellei, MSc, PhD</last_name>
    <phone>+39 059 422 4020</phone>
    <email>monica.bellei@unimore.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emanuela A. Pesce, MSc,PhD</last_name>
    <phone>+39 059 422 2577</phone>
    <email>emanuelaanna.pesce@unimore.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stanford University Medical Center</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shideh Chinichian</last_name>
      <phone>650-736-4393</phone>
      <email>shidehc@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Rajana Advani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale Cancer Center</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>St Louis Washington University</name>
      <address>
        <city>St Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Tookie Anderson</last_name>
      <email>manderso@dom.wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Kenneth Carson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carolyn Chamberlain, MD</last_name>
      <phone>402-559-7507</phone>
      <email>cchamberlain@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Julie M Vose, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan-Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erika Pamer</last_name>
      <phone>646-227-2139</phone>
      <email>pamere1@mskcc.org</email>
    </contact>
    <investigator>
      <last_name>Steven Horwitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic Foundation</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shawn Morgan, MD</last_name>
      <phone>713-792-2860</phone>
      <email>smorgan@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Barbara Pro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fred Hutchinson Cancer Research Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kari Blankenship</last_name>
      <email>kblanchen@seattlecca.org</email>
    </contact>
    <investigator>
      <last_name>Andrei Shustov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Italiano</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1896</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria V Prates, MD</last_name>
      <phone>0054-221-4176702</phone>
      <email>mvprates@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Jorge Milone, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital San Martìn</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marta Gelemur, MD</last_name>
      <phone>+54 221 4251717</phone>
      <email>hemato_sm@yahoo.com.ar</email>
    </contact>
    <investigator>
      <last_name>Lucia Zoppegno, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fundacion Fundaleu</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1114AAN</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariana Juni, MD</last_name>
      <phone>+541 4 877 1000</phone>
      <email>mjuni@fundaleu.org.ar</email>
    </contact>
    <investigator>
      <last_name>Astrid Pavlovsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Campinas</name>
      <address>
        <city>Campinas</city>
        <state>SP</state>
        <zip>13083-97</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brunna Eulalio, MD</last_name>
      <phone>+55-19-35218740</phone>
      <email>brunnaeulalio@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Carmino de Souza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Santa Casa Medical School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>01223</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Martucci, MD</last_name>
      <phone>0055-11-21767256</phone>
      <email>martuccid@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Carlos Chiattone, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital del Salvador SSMO</name>
      <address>
        <city>Santiago de Chile</city>
        <zip>3580000</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria E. Cabrera, MD</last_name>
      <phone>+56 2 3404347</phone>
      <email>mecabrera@vtr.net</email>
    </contact>
    <investigator>
      <last_name>Maria E. Cabrera, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Princess Margaret Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Tuen Mun Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>China</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hopital St Louis</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Petrovanu</last_name>
      <email>cynthia.petrovanu@sls.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Catherine Thieblemont, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sheba Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Ribakovsky, MD</last_name>
      <phone>972-3-530-5830</phone>
      <email>lenaribakovsky@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Arnon Nagler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sourasky Medical Center</name>
      <address>
        <city>Tel-Aviv</city>
        <zip>64239</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Presidio Spedali Civili</name>
      <address>
        <city>Brescia</city>
        <state>BS</state>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chiara Bottelli, MD</last_name>
      <phone>+39 030 399 6569</phone>
      <email>chiarabottelli@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Rossi, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Croce e Carle</name>
      <address>
        <city>Cuneo</city>
        <state>CN</state>
        <zip>12100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Garibaldi-Nesima</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ugo Consoli, MD</last_name>
      <phone>+39 095 7595057</phone>
      <email>ugo.consoli@tin.it</email>
    </contact>
    <investigator>
      <last_name>Patrizia Guglielmo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda O.U. Vittorio Emanuele-Ferrarotto-S. Bambino</name>
      <address>
        <city>Catania</city>
        <state>CT</state>
        <zip>95124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luciana Schinocca, MD</last_name>
      <phone>+39 095 743 5969</phone>
      <email>lu.schinocca@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Di Raimondo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Pugliese-Ciaccio</name>
      <address>
        <city>Catanzaro</city>
        <state>CZ</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato Cantaffa, MD</last_name>
      <phone>+39 0961 883120</phone>
      <email>cantaffa@tiscalinet.it</email>
    </contact>
    <investigator>
      <last_name>Renato Cantaffa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Casa Sollievo della Sofferenza IRCCS</name>
      <address>
        <city>S. Giovanni Rotondo</city>
        <state>FG</state>
        <zip>71013</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marzia Tricarico, MD</last_name>
      <phone>+39 0882 410 022</phone>
      <email>m.tricarico@operapadrepio.it</email>
    </contact>
    <investigator>
      <last_name>Nicola Cascavilla, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <state>LE</state>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Quintavalle</last_name>
      <phone>+39 0832 661923</phone>
      <email>quinta.ematolecce@libero.it</email>
    </contact>
    <investigator>
      <last_name>Nicola Di Renzo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile</name>
      <address>
        <city>Civitanova Marche</city>
        <state>Macerata</state>
        <zip>62012</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rossana Re, MD</last_name>
      <phone>0039-0733-823016</phone>
      <email>rossanare1@virgilio.it</email>
    </contact>
    <investigator>
      <last_name>Riccardo Centurioni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Ospedali Riuniti Papardo-Piemonte</name>
      <address>
        <city>Messina</city>
        <state>ME</state>
        <zip>98158</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donato Mannina, MD</last_name>
      <phone>+39 090 399 2253</phone>
      <email>donadani@tiscalinet.it</email>
    </contact>
    <investigator>
      <last_name>Maura Brugiatelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Balzarotti, MD</last_name>
      <phone>+39 02 8224 3505</phone>
      <email>monica.balzarotti@humanitas.it</email>
    </contact>
    <investigator>
      <last_name>Armando Santoro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Scientifico Universitario San Raffaele</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefania Trinca, MD</last_name>
      <phone>+39 02 2643 3919</phone>
      <email>trinca.stefania@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Andres Ferreri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Europeo di Oncologia</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liliana Calabrese, MD</last_name>
      <phone>+39 02 5748 9536</phone>
      <email>liliana.calabrese@ieo.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Martinelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Ospedale Niguarda Ca' Franda</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Basilico, MD</last_name>
      <phone>+39 02 6444 2668</phone>
      <email>claudia.basilico@ospedaleniguarda.it</email>
    </contact>
    <investigator>
      <last_name>Enrica Morra, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Oncologico Modenese</name>
      <address>
        <city>Modena</city>
        <state>MO</state>
        <zip>41124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>T-Cell Project Trial Office</last_name>
      <email>info@tcellproject.org</email>
    </contact>
    <investigator>
      <last_name>Massimo Federico, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Madonna delle Grazie</name>
      <address>
        <city>Matera</city>
        <state>MT</state>
        <zip>75100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alberto Fragasso, MD</last_name>
      <phone>+39 0835 253 032</phone>
      <email>alberto.fragasso@libero.it</email>
    </contact>
    <investigator>
      <last_name>Alberto Fragasso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Casa di Cura La Maddalena</name>
      <address>
        <city>Palermo</city>
        <state>Pa</state>
        <zip>90100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Renato Scalone, MD</last_name>
      <phone>+39 091 680 6523</phone>
      <email>rscalone@libero.it</email>
    </contact>
    <investigator>
      <last_name>Maurizio Musso, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto Oncologico Veneto</name>
      <address>
        <city>Padova</city>
        <state>PD</state>
        <zip>35128</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Savina Aversa, MD</last_name>
      <phone>+39 049 8215 931</phone>
      <email>savina.aversa@ioveneto.it</email>
    </contact>
    <investigator>
      <last_name>Savina Aversa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro di Riferimento Oncologico</name>
      <address>
        <city>Aviano</city>
        <state>Pordenone</state>
        <zip>33081</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Ravaioli, MD</last_name>
      <phone>0039-0434-659-078</phone>
      <email>eravaioli@cro.it</email>
    </contact>
    <investigator>
      <last_name>Michele Spina, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Bianchi-Melacrino-Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <state>RC</state>
        <zip>89100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisa Montechiarello</last_name>
      <phone>+39 0965 397 222</phone>
      <email>elisa862@alice.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Nobile, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcispedale S. Maria Nuova</name>
      <address>
        <city>Reggio Emilia</city>
        <state>RE</state>
        <zip>42100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caterina Mammi, MD</last_name>
      <phone>+39 0522 296 623</phone>
      <email>caterina.mammi@asmn.re.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Merli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Umberto I</name>
      <address>
        <city>Nocera Inferiore</city>
        <state>SA</state>
        <zip>84014</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Concetta Ingenito, MD</last_name>
      <phone>+39 081 921 3370</phone>
      <email>medint.nocera@libero.it</email>
    </contact>
    <investigator>
      <last_name>Alfonso M. D'Arco, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Giovanni Battista</name>
      <address>
        <city>Torino</city>
        <state>TO</state>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giorgio Priolo, MD</last_name>
      <phone>+39 011 633 5611</phone>
      <email>gpriolo2@molinette.piemonte.it</email>
    </contact>
    <investigator>
      <last_name>Umberto Vitolo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Istituto di Ematologia A &amp; Seragnoli</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Argnani, MD</last_name>
      <phone>0039-051-6363973</phone>
      <email>lisa.argnani@unibo.it</email>
    </contact>
    <investigator>
      <last_name>Michele Baccarani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Centrale di Bolzano</name>
      <address>
        <city>Bolzano</city>
        <zip>39100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlo Rosanelli</last_name>
      <phone>0039-0471-908388</phone>
      <email>carlo.rosanelli@asbz.it</email>
    </contact>
    <investigator>
      <last_name>Sergio Cortelazzo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale A. Perrino</name>
      <address>
        <city>Brindisi</city>
        <zip>72100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonia Zonno</last_name>
      <phone>0039-0831-537-506</phone>
      <email>a.zonno@inwind.it</email>
    </contact>
    <investigator>
      <last_name>Giovanni Quarta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Oncologico A. Businco</name>
      <address>
        <city>Cagliari</city>
        <zip>09121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria G Cabras, MD</last_name>
      <phone>0039-070-6095221</phone>
      <email>cabras.giuseppina@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Maria G Cabras, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Pugliese-Ciaccio</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosanna Mirabelli, MD</last_name>
      <phone>0961/883001</phone>
      <email>oncocz@libero.it</email>
    </contact>
    <investigator>
      <last_name>Stefano Molica, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Careggi</name>
      <address>
        <city>Firenze</city>
        <zip>50134</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luigi Rigacci, MD</last_name>
      <phone>0039-055-794-7958</phone>
      <email>luigi.rigacci@unifi.it</email>
    </contact>
    <investigator>
      <last_name>Luigi Rigacci, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Felettino</name>
      <address>
        <city>La Spezia</city>
        <zip>19100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annunziata Manna, MD</last_name>
      <phone>0039-187-533-057</phone>
      <email>annunziata.manna@asl5.liguria.it</email>
    </contact>
    <investigator>
      <last_name>Annunziata Manna, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico MaRe IRCCS</name>
      <address>
        <city>Milano</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Olivero, MD</last_name>
      <phone>0039-02-5503-3462</phone>
    </contact>
    <investigator>
      <last_name>Luca Baldini, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Federico II</name>
      <address>
        <city>Napoli</city>
        <zip>80130</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amalia De Renzo, MD</last_name>
      <phone>0039-081-7462055</phone>
      <email>aderenzo@unina.it</email>
    </contact>
    <investigator>
      <last_name>Fabrizio Pane, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Maggiore della Carità</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Franceschetti, MD</last_name>
      <phone>+39 0321 660655</phone>
      <email>silvia.franceschetti@med.unipmn.it</email>
    </contact>
    <investigator>
      <last_name>Gianluca Gaidano, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria</name>
      <address>
        <city>Parma</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Violi</last_name>
      <email>cri.violi@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Francesca Re, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Santo Spirito</name>
      <address>
        <city>Pescara</city>
        <zip>65100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona Falorio</last_name>
      <phone>0039-085-4252838</phone>
      <email>simonafalorio@libero.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Angrilli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Guglielmo da Saliceto</name>
      <address>
        <city>Piacenza</city>
        <zip>29100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annalisa Arcari, MD</last_name>
      <phone>003-0523-303731</phone>
      <email>a.arcari@ausl.pc.it</email>
    </contact>
    <investigator>
      <last_name>Daniele Vallisa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Universitaria Pisana</name>
      <address>
        <city>Pisa</city>
        <zip>56100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriele Buda, MD</last_name>
      <phone>0039-050-992072</phone>
      <email>ga.buda@libero.it</email>
    </contact>
    <investigator>
      <last_name>Francesco Caracciolo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Università La Sapienza</name>
      <address>
        <city>Roma</city>
        <zip>00161</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Di Rocco</last_name>
      <phone>0039-06-8579-5424</phone>
      <email>dirocco@bce.uniroma1.it</email>
    </contact>
    <investigator>
      <last_name>Maurizio Martelli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Vincenzo</name>
      <address>
        <city>Taormina</city>
        <zip>85123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giuseppe Mineo, MD</last_name>
      <phone>0942 579 393</phone>
      <email>giuseppe.mineo65@tiscali.it</email>
    </contact>
    <investigator>
      <last_name>Giuseppe Mineo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Moscati</name>
      <address>
        <city>Taranto</city>
        <zip>74100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrizio Mazza, MD</last_name>
      <phone>0039-099-4585-796</phone>
      <email>patrizio.mazza@libero.it</email>
    </contact>
    <investigator>
      <last_name>Patrizio Mazza, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera S. Maria</name>
      <address>
        <city>Terni</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viviana Appolloni</last_name>
      <email>appolloniviviana@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Anna Marina Liberati, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile SS. Giovanni e Paolo</name>
      <address>
        <city>Venezia</city>
        <zip>30123</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simona Sannicolò</last_name>
      <phone>0039-041-965-7330</phone>
      <email>ocve.ematologia@ulss12.ve.it</email>
    </contact>
    <investigator>
      <last_name>Teodoro Chisesi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>135-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin Y Hwang</last_name>
      <phone>00822-3410-6548</phone>
      <email>spica1113@nate.com</email>
    </contact>
    <investigator>
      <last_name>Won S Kim, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nacional Cancer Institute</name>
      <address>
        <city>Bratislava</city>
        <zip>40138</zip>
        <country>Slovakia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Veronika Ballova, MD</last_name>
      <phone>+421 02 5937 2272</phone>
      <email>veronika.ballova@nou.sk</email>
    </contact>
    <investigator>
      <last_name>Veronika Ballova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivan Dlouhy, MD</last_name>
      <phone>93 227 54 75</phone>
      <email>IDLOUHY@clinic.ub.es</email>
    </contact>
    <investigator>
      <last_name>Armando Lopez Guillermo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario</name>
      <address>
        <city>Salamanca</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam López Parra, MD</last_name>
      <email>miriamlopezparra@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Dolores Caballero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital</name>
      <address>
        <city>Aarau</city>
        <state>AG</state>
        <zip>5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Giovanni</name>
      <address>
        <city>Bellinzona</city>
        <state>TI</state>
        <zip>6500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emanuele Zucca, PD</last_name>
      <phone>+41 (0)91 811 80 49</phone>
      <email>emanuele.zucca@eoc.ch</email>
    </contact>
    <investigator>
      <last_name>Emanuele Zucca, PD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital St. Gallen</name>
      <address>
        <city>St. Gallen</city>
        <zip>9007</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabriela Kramer</last_name>
      <phone>0041-71-4941099</phone>
      <email>gabriela.kramer@kssg.ch</email>
    </contact>
    <investigator>
      <last_name>Felicitas Hitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Arrazi</last_name>
      <email>julie.arrazi@uhb.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Martin Rowe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Barths and The London NHS Trust</name>
      <address>
        <city>London</city>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Montoto, MD</last_name>
      <phone>+44 207 601 7456</phone>
      <email>s.montoto@qmul.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Silvia Montoto, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <zip>SE19RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Christie Hospital NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <zip>M20 4BX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emma Burke, MD</last_name>
      <phone>+44 161 446 8148</phone>
      <email>emma.burke@christie-tr.nwest.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>John Radford, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Newcastle University</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <zip>NE17RU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Southampton School of Medicine</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leanne Byrne</last_name>
      <phone>023-80-7777222</phone>
      <phone_ext>8285</phone_ext>
      <email>l.byrne@soton.ac.uk</email>
    </contact>
    <investigator>
      <last_name>Peter Johnson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 OQP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Maciel</name>
      <address>
        <city>Montevideo</city>
        <zip>11000</zip>
        <country>Uruguay</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isabel Moro, MD</last_name>
      <phone>+59824099160</phone>
      <email>isamorog@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Raul Gabus, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>Chile</country>
    <country>China</country>
    <country>France</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
    <country>Uruguay</country>
  </location_countries>
  <link>
    <url>http://www.tcellproject.org</url>
    <description>Click here for more information about the T-Cell Project</description>
  </link>
  <reference>
    <citation>Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999 Dec;17(12):3835-49.</citation>
    <PMID>10577857</PMID>
  </reference>
  <reference>
    <citation>Jones D, O'Hara C, Kraus MD, Perez-Atayde AR, Shahsafaei A, Wu L, Dorfman DM. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000 Jul 15;96(2):685-90.</citation>
    <PMID>10887135</PMID>
  </reference>
  <reference>
    <citation>Picker LJ, Weiss LM, Medeiros LJ, Wood GS, Warnke RA. Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol. 1987 Jul;128(1):181-201. Review.</citation>
    <PMID>3111266</PMID>
  </reference>
  <reference>
    <citation>Cooke CB, Krenacs L, Stetler-Stevenson M, Greiner TC, Raffeld M, Kingma DW, Abruzzo L, Frantz C, Kaviani M, Jaffe ES. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin. Blood. 1996 Dec 1;88(11):4265-74.</citation>
    <PMID>8943863</PMID>
  </reference>
  <reference>
    <citation>Melnyk A, Rodriguez A, Pugh WC, Cabannillas F. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood. 1997 Jun 15;89(12):4514-20.</citation>
    <PMID>9192775</PMID>
  </reference>
  <reference>
    <citation>Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol. 1998 Aug;16(8):2780-95.</citation>
    <PMID>9704731</PMID>
  </reference>
  <reference>
    <citation>Ascani S, Zinzani PL, Gherlinzoni F, Sabattini E, Briskomatis A, de Vivo A, Piccioli M, Fraternali Orcioni G, Pieri F, Goldoni A, Piccaluga PP, Zallocco D, Burnelli R, Leoncini L, Falini B, Tura S, Pileri SA. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol. 1997 Jun;8(6):583-92.</citation>
    <PMID>9261528</PMID>
  </reference>
  <reference>
    <citation>López-Guillermo A, Cid J, Salar A, López A, Montalbán C, Castrillo JM, González M, Ribera JM, Brunet S, García-Conde J, Fernández de Sevilla A, Bosch F, Montserrat E. Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification. Ann Oncol. 1998 Aug;9(8):849-55. Review.</citation>
    <PMID>9789607</PMID>
  </reference>
  <reference>
    <citation>Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM. Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol. 2004 Oct;15(10):1467-75.</citation>
    <PMID>15367405</PMID>
  </reference>
  <reference>
    <citation>Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U, Morabito F, Martelli M, Brusamolino E, Iannitto E, Zaja F, Cortelazzo S, Rigacci L, Devizzi L, Todeschini G, Santini G, Brugiatelli M, Federico M; Intergruppo Italiano Linfomi. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood. 2004 Apr 1;103(7):2474-9. Epub 2003 Nov 26.</citation>
    <PMID>14645001</PMID>
  </reference>
  <reference>
    <citation>Zaja F, Russo D, Silvestri F, Fanin R, Damiani D, Infanti L, Salmaso F, Mariuzzi L, Di Loreto C, Baccarani M. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome. Haematologica. 1997 Mar-Apr;82(2):171-7.</citation>
    <PMID>9175321</PMID>
  </reference>
  <reference>
    <citation>Tsuchiya T, Ohshima K, Karube K, Yamaguchi T, Suefuji H, Hamasaki M, Kawasaki C, Suzumiya J, Tomonaga M, Kikuchi M. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood. 2004 Jan 1;103(1):236-41. Epub 2003 Sep 4.</citation>
    <PMID>12958063</PMID>
  </reference>
  <results_reference>
    <citation>Federico M, Bellei M, Pesce, E, Zucca E, Pileri S, Montoto S, Weisenburger DD, Ruediger T, KO YH, Liang R, Zinzani PL, Connors JM, Foss FM, Horwitz SM, Polliack A, Vose JM. T-Cell Project: an international, longitudinal, observational study of patients with aggressive peripheral T-cell lymphoma. Revista Brasileira de Hematologia e Hemoterapia 31(suppl 2):21-25,2009.</citation>
  </results_reference>
  <results_reference>
    <citation>Federico M, Bellei M, Pesce EA, Zucca E, Pielri S, Montoto S, Weisenburger D, Rugiger T, Ko Y, Liang R, Zinzani PL, Connors J, Foss F, Horwitz S, Polliack A, Vose J. T-Cell Project: an international, prospective, observational study of patients with aggressive Peripheral T-cell Lymphoma. Analysis of the first 524 patients. 11 ICML, Lugano (Switzerland), 15-18 June 2011. Abs 241. Ann Oncol 22 (suppl 4), 2011</citation>
  </results_reference>
  <results_reference>
    <citation>Bellei M, Chiattone CS, Luminari S, Pesce EA, Cabrera ME, de Souza CA, Gabús R, Zoppegno L, Zoppegno L, Milone J, Pavlovsky A, Connors JM, Foss FM, Horwitz SM, Liang R, Montoto S, Pileri SA, Polliack A, Vose JM, Zinzani PL, Zucca E, Federico M. T-cell lymphomas in South america and europe. Rev Bras Hematol Hemoter. 2012;34(1):42-7. doi: 10.5581/1516-8484.20120013.</citation>
    <PMID>23049383</PMID>
  </results_reference>
  <results_reference>
    <citation>Federico M, Bellei M, Luminari S, Horwitz SM, Montoto S, Zucca E, Pileri SA, Ko YH, Zinzani PL, Connors JM, Foss FM, Polliack A, Cabrera ME, Kim WS, Spina M, De Souza CA, Bobillo Varela S, Dlouhy I, Advani RH, Vose J and T-Cell Project. CD30+ expression in Peripheral T-cell lymphomas (PTCLs): A subset analysis from the international, prospective T-Cell Project. Journal of Clinical Oncology, 2015 ASCO Annual Meeting (May 29 - June 2, 2015).Vol 33, No 15_suppl (May 20 Supplement), 2015: 8552</citation>
  </results_reference>
  <results_reference>
    <citation>Federico M, Bellei M, Pesce EA, et al. T-Cell Project: an international, prospective, observational study of patients with aggressive Peripheral NK/T-Cell Lymphoma: Lesson from the first 1308 patients. 13 ICML, Lugano (Switzerland) 17-20 June, 2015. Abstract 070. Hematol Oncol 2015; 33(Suppl1):100-180</citation>
  </results_reference>
  <results_reference>
    <citation>Bellei M, Marcheselli L, Pesce EA, et al. Clinical Characteristics and Patterns of Care of Patients (pts) with Peripheral T-cell Lymphoma (PTCLs) according to age at time of diagnosis: A T-Cell Project snapshot. 13 ICML, Lugano (Switzerland) 17-20 June, 2015. Abstract 231. Hematol Oncol 2015; 33(Suppl1):181-243</citation>
  </results_reference>
  <results_reference>
    <citation>Horwitz SM, Bellei M, Marcheselli L, et al. The role of transplant in the treatment of Peripheral T-cell Lymphomas (PTCLs): an analysis from the T-cell Project database. 13 ICML, Lugano (Switzerland) 17-20 June, 2015. Abstract 247. Hematol Oncol 2015; 33(Suppl1):181-243</citation>
  </results_reference>
  <results_reference>
    <citation>Bellei M, Sabattini E, Pesce EA, Ko YH, Kim WS, Cabrera ME, Martinez V, Dlouhy I, Paes RP, Barrese T, Vassallo J, Tarantino V, Vose J, Weisenburger D, Rüdiger T, Federico M, Pileri S. Pitfalls and major issues in the histologic diagnosis of peripheral T-cell lymphomas: results of the central review of 573 cases from the T-Cell Project, an international, cooperative study. Hematol Oncol. 2017 Dec;35(4):630-636. doi: 10.1002/hon.2316. Epub 2016 Jun 3.</citation>
    <PMID>27255982</PMID>
  </results_reference>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2010</study_first_submitted>
  <study_first_submitted_qc>June 10, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2010</study_first_posted>
  <last_update_submitted>August 8, 2016</last_update_submitted>
  <last_update_submitted_qc>August 8, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 9, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lymphoma, T-Cell, Peripheral</keyword>
  <keyword>Prognosis</keyword>
  <keyword>Outcome</keyword>
  <keyword>International Cooperation</keyword>
  <keyword>Biological Characteristics</keyword>
  <keyword>Heterogeneity</keyword>
  <keyword>Rare Diseases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Lymphoma, T-Cell</mesh_term>
    <mesh_term>Lymphoma, T-Cell, Peripheral</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Preliminary analysis results will be made available during the study on the single population and separately for each subtype. Final results will be made available 6-12 months after the end of the study</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

